160 related articles for article (PubMed ID: 34972249)
21. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
22. Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis.
Liu FY; Li XZ; Peng YM; Liu H; Liu YH
Am J Nephrol; 2007; 27(2):176-83. PubMed ID: 17347560
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.
Feng F; Li N; Cheng P; Zhang H; Wang H; Wang Y; Wang W
Biomed Pharmacother; 2020 Jan; 121():109586. PubMed ID: 31706104
[TBL] [Abstract][Full Text] [Related]
25. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
[TBL] [Abstract][Full Text] [Related]
26. Current perspectives on inhibitory SMAD7 in health and disease.
de Ceuninck van Capelle C; Spit M; Ten Dijke P
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
[TBL] [Abstract][Full Text] [Related]
27. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
[TBL] [Abstract][Full Text] [Related]
28. SETD2 deficiency promotes renal fibrosis through the TGF-β/Smad signalling pathway in the absence of VHL.
Liu C; Ni L; Li X; Rao H; Feng W; Zhu Y; Zhang W; Ma C; Xu Y; Gui L; Wang Z; Aji R; Xu J; Gao WQ; Li L
Clin Transl Med; 2023 Nov; 13(11):e1468. PubMed ID: 37933774
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
30. TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review).
Li J; Zou Y; Kantapan J; Su H; Wang L; Dechsupa N
Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38904198
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN.
Li J; Zhang Z; Wang D; Wang Y; Li Y; Wu G
J Recept Signal Transduct Res; 2009; 29(5):280-5. PubMed ID: 19640259
[TBL] [Abstract][Full Text] [Related]
32. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Wang WM; Liu F; Chen N
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
[TBL] [Abstract][Full Text] [Related]
33. [Effects and mechanisms of UCG ameliorating renal interstitial fibrosis by regulating TGF-β1/SnoN/Smads signaling pathway in renal failure rats].
Wu W; Huang YR; Wan YG; Yang HM; Mao ZM; Yang JJ; Shi G; Sun W
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2291-2297. PubMed ID: 28901075
[TBL] [Abstract][Full Text] [Related]
34. Smads as therapeutic targets for chronic kidney disease.
Lan HY
Kidney Res Clin Pract; 2012 Mar; 31(1):4-11. PubMed ID: 26889404
[TBL] [Abstract][Full Text] [Related]
35. Smad7 as a therapeutic agent for chronic kidney diseases.
Lan HY
Front Biosci; 2008 May; 13():4984-92. PubMed ID: 18508563
[TBL] [Abstract][Full Text] [Related]
36. Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease.
Zhang ZH; Li MH; Liu D; Chen H; Chen DQ; Tan NH; Ma SC; Zhao YY
Front Pharmacol; 2018; 9():1029. PubMed ID: 30271345
[TBL] [Abstract][Full Text] [Related]
37. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
39. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.
Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF
J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426
[TBL] [Abstract][Full Text] [Related]
40. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.
Li JH; Zhu HJ; Huang XR; Lai KN; Johnson RJ; Lan HY
J Am Soc Nephrol; 2002 Jun; 13(6):1464-72. PubMed ID: 12039975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
